Original Research
Published on 11 Jun 2024
Active and machine learning-enhanced discovery of new FGFR3 inhibitor, Rhapontin, through virtual screening of receptor structures and anti-cancer activity assessment
in Biological Modeling and Simulation

- 607 views













